Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Atossa, BMS, Innocare, Kymera, Praxis, Sanofi, Serina.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Peijia Medical, Ruthless Spine, Zenflow.
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Ajax, Amneal, Beren, Boehringer, Fondazione, GSK, Kane, Sagimet, USAntibiotics.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Flow Neuroscience, Vesalio.
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Askbio, Biogen, Opus, OS Therapies, Roche, Senti, Teva, Tris.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bendit Technologies, Heartbeam, Kane Biotech, Proverum, Vektor Medical.
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Ayrmid, Incyte, Junshi, Ocular.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ceribell, MMI.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ascentage, Biogen, Celltrion, Cosmo, Iaso, Innovent.